Skip to main content

Wilton Bryan Williams

Associate Professor in Surgery
Surgery, Surgical Sciences
Box 103010, Durham, NC 27710
2 Genome Ct, Durham, NC 27710

Overview


Dr. Williams completed a PhD in Biomedical Sciences (Immunology and Microbiology) from the University of Florida and did his postdoctoral work in the laboratory of Dr. Barton Haynes at the Duke Human Vaccine Institute (DHVI).

The key goals of HIV vaccine development are to define the host-virus events during natural HIV infection that lead to the induction of broadly neutralizing antibodies, and to recreate those events with a vaccine. As a junior faculty member in the DHVI, Dr. Williams is further characterizing SHIV non-human primate models for HIV infection, and evaluates B cell responses to HIV-1 vaccination in humans and non-human primates.

Current Appointments & Affiliations


Associate Professor in Surgery · 2021 - Present Surgery, Surgical Sciences, Surgery
Assistant Professor in Integrative Immunobiology · 2021 - Present Integrative Immunobiology, Basic Science Departments
Associate Professor of Medicine · 2021 - Present Medicine, Duke Human Vaccine Institute, Medicine
Member of the Duke Human Vaccine Institute · 2016 - Present Duke Human Vaccine Institute, Institutes and Centers
Member of the Duke Cancer Institute · 2021 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published May 20, 2024
Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans
Published October 11, 2022
Federal Grant to Duke University School of Medicine Expands HIV Research
Published May 20, 2021
Newly Identified Antibody Can Be Targeted by HIV Vaccines

View All News

Recent Publications


An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.

Journal Article medRxiv · August 22, 2025 UNLABELLED: Broadly neutralizing antibodies (bnAbs) that target the HIV gp41 membrane-proximal external region (MPER) have some of the highest neutralization breadth. An MPER peptide-liposome vaccine has been found to expand MPER bnAb precursors in monkeys ... Full text Link to item Cite

Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques.

Journal Article Nat Commun · November 27, 2024 The details of the pediatric immune system that supports induction of antibodies capable of neutralizing geographically-diverse or heterologous HIV-1 is currently unclear. Here we explore the pediatric immune environment in neonatal macaque undergoing Simi ... Full text Link to item Cite

Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques.

Journal Article Sci Immunol · August 30, 2024 Adolescents are a growing population of people living with HIV. The period between weaning and sexual debut presents a low-risk window for HIV acquisition, making early childhood an ideal time for implementing an immunization regimen. Because the elicitati ... Full text Link to item Cite
View All Publications

Recent Grants


Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030

Persistent Immunogenicity of IDLV delivering membrane tethered Native-Like HIV-1 Envelope Trimers

ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2025 - 2030

Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030

View All Grants

Education, Training & Certifications


University of Florida · 2011 Ph.D.